FDG-PET for evaluation of recurrent lymph node metastases in patients with surgically resected breast cancer: Adding spot images to whole body images

Breast Cancer

Volumn 11, Issue 1, 2004, Pages 60-64

  Tamaki, Tsuneo ^a   Naito, Akihiro ^a   Nishio, Masami ^a   Kawahara, Katsuhiko ^b  

^a NAGOYA KYORITSU HOSPITAL   (Japan)

^b Nagoya PET Imaging Center   (Japan)

Author keywords

Breast cancer; FDG PET; Lymph node metastases

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BREAST TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MASTECTOMY; METHODOLOGY; MIDDLE AGED; TUMOR RECURRENCE;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1542379869     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02968004     Document Type: Article

References (19)

1. Liu CS, Shen YY, Lin CC, Yen RF, Kao CH: Clinical Impact of [18F]FDG-PET in Patients with Suspected Recurrent Breast Cancer Based on Asymptomatically Elevated Tumor Marker Serum Levels: a Preliminary Report. Jpn J Clin Onco132:244-247, 2002.
2. Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, Lind P: F-18 Fluorodeoxyglucose Positron-Emission Tomography in the Diagnosis of Tumor Recurrence and Metastases in the Follow-Up of Patients With Breast Carcinoma: A Comparison to Conventional Imaging. Investigative Radiology 38:250-256, 2003. (Pubitemid 36535030)
3. Liu CS, Shen YY, Hn CC, Yen RF, Kao CH: Clinical Impact of [18F]FDG-PET in Patients with Suspected Recurrent Breast Cancer Based on Asymptomatically Elevated Tumor Marker Serum Levels: a Preliminary Report. Jpn J Clin Onco132:244-247, 2002.
4. Dose J, Bleckmann C, Bachmann S, Bohuslavizki KH, Berger J, Jenicke L, Habermann CR, Jänicke F: Comparison of fluorodeoxyglucose positron emission tomography and 'conventional diagnostic procedures' for the detection of distant metastases in breast cancer patients. Nuclear Medicine Communications 23:857-864, 2002.
5. Vranjesevic D, Filmont JE, Meta J, Silverman DH, Phelps ME, Rao J, Valk PE, Czernin J: Whole-Body 18F-FDG PET and Conventional Imaging for Predicting Outcome in Previously Treated Breast Cancer Patients. J Nucl Med 43:325-329, 2002. (Pubitemid 34208093)
6. Eubank WB, Mankoff DA, Vesselle HJ, Eary JF, Schubert EK, Dunnwald LK, Hndsley SK, Gralow JR, Austin-Seymour MM, Ellis GK, Livingston RB: Detection of Locoregional and Distant Recurrences in Breast Cancer Patients by Using FDG PET. Radio Graphics 22:5-17, 2002.
7. Moon DH, Maddahi J, Silverman DH, Glaspy JA, Phelps ME, Hoh CK: Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med 39:431-435, 1998. (Pubitemid 28136839)
8. Smith IC, Ogston KN, Whifford P, Smith FW, Sharp P, Norton M, Miller ID, All-See AK, Heys SD, Jibril JA, Eremin O: Staging of the Axilla in Breast Cancer Accurate In Vivo Assessment Using Positron Emission Tomography With 2-(Fluorine-18)-Fluoro-2-Deoxy-D-Glucose. Annals of Surgery 228:220-227, 1998. (Pubitemid 30191718)
9. Crippa F, Agresti R, Seregni E, Greco M, Pascali C, Bogni A, Chiesa C, De Sanctis V, Delledonne V, Salvadori B, Leutner M, Bombardieri E: Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer. J Nucl Med 39:4-8, 1998. (Pubitemid 28063164)
10. Adler LP, Faulhaber PF, Schnur KC, A1-Kasi NL, Shenk RR: Axillary lymph node metastases: screening with [F-1812-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 203:323-327, 1997. (Pubitemid 27176199)
11. Bassa P, Kim EE, Inoue T, Wong FC, Korkmaz M, Yang D J, Wong WH, Hicks KW, Buzdar AU, Podoloff DA: Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer. JNucl Med 37:931-938, 1996. (Pubitemid 126447124)
12. Greco M, Crippa F, Agresti R, Seregni E, Gerali A, Giovanazzi R, Micheli A, Asero S, Ferraris C, Gennaro M, Bombardieri E, Cascinelli N: Axillary Lymph Node Staging in Breast Cancer by 2-Fluoro-2-deoxy-D-glucose-Positron Emission Tomography: Clinical Evaluation and Alternative Management. J Natl Cancer Inst 93:630-635 2001. (Pubitemid 32409630)
13. van der Hoeven JJM, Hoekstra OS, Comans EFI, Pijpers R, Boom RPA, van Geldere D, Meijer S, Lammertsma AA, Teule GJJ: Determinants of Diagnostic Performance Of [F-18] Fluorodeoxyglucose Positron Emission Tomography for Axillary Staging in Breast Cancer. Annals of Surgery 236:619-624, 2002. (Pubitemid 35246894)
14. Yang JH, Nam SJ, Lee TS, Lee HK, Jung SH, Kim BT: Comparison of Intraoperative Frozen Section Analysis of Sentinel Node with Preoperative Positron Emission Tomography in the Diagnosis of Axillary Lymph Node Status in Breast Cancer Patients. Jpn J Clin Onco131:1-6, 2001. (Pubitemid 32236879)
15. Barranger E, Grahek D, Antoine M, Montravers F, Talbot JN, Uzan S: Evaluation of Fluorodeoxyglucose Positron Emission Tomography in the Detection of Axillary Lymph Node Metastases in Patients With Early-Stage Breast Cancer. Ann Surg Oncol 10:622-627, 2003. (Pubitemid 40486893)
16. Avril N, Menzel M, Dose J, Schelling M, Weber W, Jänicke F, Nathrath W, Schwaiger M: Glucose Metabolism of Breast Cancer Assessed by 18F-FDG PET: Histologic and Immunohistochemical Tissue Analysis. J Nucl Med 42:9-16, 2001. (Pubitemid 32104770)
17. Alexander Matthies, Marc Hickeson, Andrew Cuchiara, and Abass Alavi: Dual Time Point 18F-FDG PET for the Evaluation of Pulmonary Nodules. J Nucl Med 43:871-875, 2002. (Pubitemid 34747808)
18. Zhuang H, Pourdehnad M, Lambright ES, Yamamoto A J, Lanuti M, Li P, Mozley PD, Rossman MD, Albelda SM, Alavi A: Dual Time Point '~F-FDG PET Imaging for Differentiating Malignant fTom Inflammatory Processes. J Nucl Med 42:1412-1417, 2001. (Pubitemid 32852620)
19. Beanlieu S, Kinahan P, Tseng J, Dunnwald LK, Schubert EK, Pham P, Lewellen B, Mankoff DA: SUV Varies with Time After Injection in 18F-FDG PET of Breast Cancer: Characterization and Method to Adjust for Time Differences. JNuel Med 44:1044-1050, 2003. (Pubitemid 39663378)